Evidence map›Paper›PMID 32605028›Full record

ArticleBiomedicines2020

Bioinformatic Analyses of miRNA-mRNA Signature during hiPSC Differentiation towards Insulin-Producing Cells upon HNF4α Mutation.

Luiza Ghila, Yngvild Bjørlykke, Thomas Aga Legøy, Heidrun Vethe, Kenichiro Furuyama, Simona Chera, Helge Ræder

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Luiza GhilaDepartment of Clinical Science, Faculty of Medicine, University of Bergen, 5021 Bergen, Norway.
Yngvild BjørlykkeDepartment of Clinical Science, Faculty of Medicine, University of Bergen, 5021 Bergen, Norway.
Thomas Aga LegøyDepartment of Clinical Science, Faculty of Medicine, University of Bergen, 5021 Bergen, Norway.
Heidrun VetheDepartment of Clinical Science, Faculty of Medicine, University of Bergen, 5021 Bergen, Norway.
Kenichiro FuruyamaDepartment of Genetic Medicine & Development, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Simona CheraDepartment of Clinical Science, Faculty of Medicine, University of Bergen, 5021 Bergen, Norway.
Helge RæderDepartment of Clinical Science, Faculty of Medicine, University of Bergen, 5021 Bergen, Norway.
University of Bergen · NOHaukeland University Hospital · NOUniversity of Geneva · CH

Funding

Bergens Forskningsstiftelse BFS2014REK02Diabetesforbundet GhilaHelse Vest Regionalt Helseføretak Bergen Stem Cell ConsortiumJohan Salmer Kvanes legat HRNorges Forskningsråd 247577Novo Nordisk Fonden NNF15OC0015054Novo Nordisk Fonden NNF17OC0027258
6 · The paper itself

Abstract

Mutations in the hepatocyte nuclear factor 4α (HNF4α) gene affect prenatal and postnatal pancreas development, being characterized by insulin-producing β-cell dysfunction. Little is known about the cellular and molecular mechanisms leading to β-cell failure as result of HNF4α mutation. In this study, we compared the miRNA profile of differentiating human induced pluripotent stem cells (hiPSC) derived from HNF4α

Indexed as

endocrinehiPSCHNF4αinsulin-producing cellsin-vitro differentiationmiRNAMODY1pancreaspluripotent stem cellsprogenitor

Identifiers

PMID32605028
PMCPMC7400504
OpenAlexW3037545470

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.